These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9743468)

  • 1. Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.
    Wan MS; Fell PL; Akhtar S
    Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):309-17. PubMed ID: 9743468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
    Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
    Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.
    Folini M; Colella G; Villa R; Lualdi S; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2000 Feb; 114(2):259-67. PubMed ID: 10651984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
    Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC
    Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
    Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
    Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
    Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
    Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes.
    Zaffaroni N; Villa R; Pennati M; Folini M
    Mini Rev Med Chem; 2003 Feb; 3(1):51-60. PubMed ID: 12570854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
    Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T
    Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibitors.
    Rowley PT; Tabler M
    Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA.
    Fell PL; Hudson AJ; Reynolds MA; Usman N; Akhtar S
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):319-26. PubMed ID: 9303183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase.
    Yokoyama Y; Wan X; Takahashi Y; Shinohara A; Liulin T; Tamaya T
    Arch Biochem Biophys; 2002 Sep; 405(1):32-7. PubMed ID: 12176054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
    Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
    Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference.
    Li S; Nosrati M; Kashani-Sabet M
    Methods Mol Biol; 2007; 405():113-31. PubMed ID: 18369821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase].
    Qu Y; Liu SQ; Peng WZ; Liu BL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibition of telomerase activity from Chinese hamster V79 cells.
    Pandit B; Bhattacharyya NP
    Indian J Biochem Biophys; 2001; 38(1-2):42-7. PubMed ID: 11563329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.